Advertisement


Johnson Johnson
India  /  Published 09.01.19

Plea for more hip cash

Patients in India who had received faulty hip implants recalled by Johnson & Johnson on Wednesday asked a government panel to raise the proposed compensation taking into account their unique circu...
By Our Special Correspondent in New Delhi

India  /  Published 17.05.20

India cuts Covid test swab price to one-tenth

As Covid-19 pandemic spread quickly, India faced twin challenge—short supply of testing swabs and those imported from China at a steep price of Rs 17 per stick were proving to be inferior.A solution...
By PTI in New Delhi

India  /  Published 29.11.18

Govt has formula for hip implant damages

The Union health ministry on Thursday approved a formula to calculate compensation amounts for patients in India who had received faulty hip implants manufactured by a Johnson & Johnson subsidiary...
By Our Special Correspondent in New Delhi

World  /  Published 27.08.19

J&J urged to pay $572m in opioid trial

A judge in Oklahoma on Monday ruled that Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids, and ordered it to pay the state $572 million in the first...
By Jan Hoffman/New York Times News Service in New York

Health  /  Published 15.10.18

Hip implant victims sceptical of fair deal

Patients in India who had received faulty hip implants from Johnson&Johnson subsidiary on Monday complained to the Union health ministry about what they say is lack of transparency and dialogue in...
By Our Special Correspondent in New Delhi

Advertisement

Opinion  /  Published 06.12.18

Corruption in the medical devices industry

Ethics, or just scruples, are no longer part of the dictionary of those working in the medical industry. A recent investigation into the supply of medical devices in India by the International Consort...
By The Editorial Board

India  /  Published 19.05.19

Hype & fizzle: Factory typifies Modinomics

It was supposed to be Johnson & Johnson’s biggest manufacturing plant in India. It was to eventually employ at least 1,500 people and help bring development to a rural area near Hyderabad.Yet, t...
By Reuters in New Delhi

India  /  Published 08.02.19

Opposition to patent on TB drug bedaquiline

Two persons who survived tuberculosis have filed an opposition to a patent application by a pharmaceutical company on bedaquiline, a medicine prescribed for multi-drug-resistant TB but still not avail...
By G.S. Mudur in New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.